Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020;85(5):88-92.
doi: 10.17116/otorino20208505188.

[Modern approaches and prospective directions in treatment of acute sensorineural hearing loss following acoustic trauma]

[Article in Russian]
Affiliations
Review

[Modern approaches and prospective directions in treatment of acute sensorineural hearing loss following acoustic trauma]

[Article in Russian]
M S Kuznecov et al. Vestn Otorinolaringol. 2020.

Abstract

The article presents a review of the literature on the treatment of acute sensorineural hearing loss, acoustic trauma in people exposed to impulse noise. Groups of the most used drugs for the pharmacological correction of hearing impairment in this pathology are present, such as glucocorticosteroids, antioxidants, nootropics, antihypoxants, and others, are covered. Particular attention is paid to use of drugs taking into account the main links of pathogenesis.

В статье представлен обзор литературы по проблеме лечения острой сенсоневральной тугоухости (ОСНТ), акустической травмы (АТ) у лиц, подвергающихся воздействию импульсного шума (ИШ). Освещены данные о группах наиболее перспективных лекарственных средств для фармакологической коррекции нарушений слуха при этой патологии, такие как глюкокортикостероиды, антиоксиданты, ноотропы, антигипоксанты и др. Особое внимание уделено обоснованию применения препаратов с учетом звеньев патогенеза заболевания.

Keywords: acoustic trauma; acute sensorineural hearing loss; antihypoxants; antioxidants; impulse noise; nootropics; treatment.

PubMed Disclaimer

MeSH terms